综合治疗慢性肾炎蛋白尿22例临床观察  被引量:7

Clinical observation on combined treatment of chronic nephritis proteinuria,a report of 22 cases

在线阅读下载全文

作  者:王超[1] 

机构地区:[1]南昌大学第四附属医院肾内科,江西省南昌330003

出  处:《中国基层医药》2016年第22期3452-3455,共4页Chinese Journal of Primary Medicine and Pharmacy

摘  要:目的:观察正清风痛宁缓释片、蚓激酶肠溶胶囊和氯沙坦钾片联合治疗慢性肾炎蛋白尿的疗效,并探讨其机制。方法慢性肾炎患者42例,采用掷硬币法随机分为两组,对照组20例,予氯沙坦钾片治疗,50 mg,每天1~2次。治疗组22例,在对照组基础上予正清风痛宁缓释片120 mg,每天2次;蚓激酶肠溶胶囊60万 u,每天3次。治疗前后观察24 h 尿蛋白、肝肾功能。结果治疗20 d 后,治疗组24 h 尿蛋白下降57.08%,对照组24 h 尿蛋白下降41.59%,治疗组较对照组尿蛋白变化差异有统计学意义(t =2.39,P <0.05)。治疗30 d 后,治疗组24 h 尿蛋白下降81.28%,对照组24 h 尿蛋白下降52.34%,差异有统计学意义(t =3.65,P <0.01)。两组肾功能改变差异无统计学意义。结论正清风痛宁缓释片、蚓激酶肠溶胶囊和氯沙坦钾片联合治疗慢性肾炎蛋白尿起效快,疗效好,不良反应小,值得推荐。Objective To observe the curative effect of Zhengqingfengtongning release tablets and lumbroki-nase enteric -coated capsules and losartan potassium tablets joint for the treatment of chronic nephritis proteinuria, and explore its mechanism.Methods 42 patients with chronic nephritis were randomly divided into two groups. 20 cases in the control group were given losartan potassium tablets,50mg,1 ~2 times a day.22 cases in the treatment group received Zhengqingfengtongning release tablets 120mg,2 times a day,lumbrokinase enteric -coated capsules 600 000u,3 times a day on the basis of the control group.The 24h urine protein,liver and kidney function before and after the treatment were observed.Results 20 days after treatment,24h urinary protein in the treatment group decreased 57.08%,which in the control group decreased 41.59%,the difference was statistically significant (t =2.39,P 〈0.05).30 days after treatment,24h urinary protein in the treatment group decreased 81.28%,which in the control group decreased 52.34%,the difference was statistically significant (t =3.65,P 〈0.01 ).Renal function change had no significant difference between the two groups.Conclusion Zhengqingfengtongning release tablets and lumbrokinase enteric -coated capsules combined with losartan potassium tablets in the treatment of chronic nephritis proteinuria work fast,and has good curative effect,less side effects,and is worth to recommend.

关 键 词:蛋白尿 肾病 脂性 正清风痛宁缓释片 蚓激酶肠溶胶囊 氯沙坦钾片 

分 类 号:R692.3[医药卫生—泌尿科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象